Home Cart Sign in  
Chemical Structure| 1176-09-6 Chemical Structure| 1176-09-6

Structure of Raptinal
CAS No.: 1176-09-6

Chemical Structure| 1176-09-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Raptinal directly activates caspase-3, initiating a caspase-dependent intrinsic apoptosis pathway. Raptinal can rapidly induce cancer cell death by directly activating effector caspase-3, bypassing the activation of initiator caspase-8 and caspase-9.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Raptinal

CAS No. :1176-09-6
Formula : C28H18O2
M.W : 386.44
SMILES Code : O=CC1(C2(C=O)C3=C(C4=C2C=CC=C4)C=CC=C3)C5=C(C6=C1C=CC=C6)C=CC=C5
MDL No. :MFCD30480931

Safety of Raptinal

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Related Pathways of Raptinal

pyroptosis

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HRMECs cells 1 µM 1 hour Activate caspase-3, promote GSDME-mediated pyroptosis Cell Death Dis. 2024 Feb 8;15(2):118
MKN28 cells 10 µM 2 hours Induced caspase-3 activation and apoptosis Cell Death Dis. 2020 Aug 21;11(8):667
MKN45 cells 10 µM 2 hours Induced caspase-3 activation and apoptosis Cell Death Dis. 2020 Aug 21;11(8):667
AGS cells 10 µM 2 hours Induced caspase-3 activation and apoptosis Cell Death Dis. 2020 Aug 21;11(8):667
Primary mouse thymocytes 10 µM 4 hours Induced apoptosis and reduced TO-PRO-3 uptake Cell Death Dis. 2024 Feb 9;15(2):123
HEK293T cells 10 µM 1 hour Inhibited PANX1 channel currents Cell Death Dis. 2024 Feb 9;15(2):123
ARPE-19 cells 2 µM 1 hour Activate caspase-3, promote GSDME-mediated pyroptosis Cell Death Dis. 2024 Feb 8;15(2):118
MIA PaCa-2 cells 10 µM 1 hour To evaluate Raptinal-induced caspase-3/7 activity via siRNA screening, results showed knockdown of multiple genes significantly reduced Raptinal-induced caspase-3/7 activity Cell Rep. 2015 Dec 1;13(9):2027-36
SKW 6.4 cells 10 µM 1 hour To assess the ability of Raptinal to activate procaspase-3, results showed Raptinal activated procaspase-3 within 1 hour Cell Rep. 2015 Dec 1;13(9):2027-36
Primary human gastric epithelial cells 10 µM 2 hours Induced caspase-3 activation and apoptosis Cell Death Dis. 2020 Aug 21;11(8):667
U-937 cells 10 µM 2 hours To evaluate the speed and effect of Raptinal-induced apoptosis, results showed Raptinal significantly reduced cell viability within 2 hours Cell Rep. 2015 Dec 1;13(9):2027-36
YUMM1.7 cells 2.5 µM 3 hours Induced GSDME-dependent pyroptosis, characterized by GSDME cleavage, HMGB1 and IL-1α/β release, and increased LDH release Mol Cancer Res. 2022 Dec 2;20(12):1811-1821
D4M3.A cells 2.5 µM 3 hours Induced GSDME-dependent pyroptosis, characterized by GSDME cleavage, HMGB1 and IL-1α/β release, and increased LDH release Mol Cancer Res. 2022 Dec 2;20(12):1811-1821
WM35 cells 2.5 µM 3 hours Induced GSDME-dependent pyroptosis, characterized by GSDME cleavage, HMGB1 and IL-1α/β release, and increased LDH release Mol Cancer Res. 2022 Dec 2;20(12):1811-1821
A375 cells 5 µM 3 hours Induced GSDME-dependent pyroptosis, characterized by GSDME cleavage, HMGB1 and IL-1α/β release, and increased LDH release Mol Cancer Res. 2022 Dec 2;20(12):1811-1821
Jurkat T cells 10 µM 4 hours Induced apoptosis and inhibited PANX1 activity, reduced TO-PRO-3 uptake and ATP release Cell Death Dis. 2024 Feb 9;15(2):123
Bone marrow-derived macrophages 10 µM 6 hours Induced apoptosis and inhibited NLRP3 inflammasome activation Cell Death Dis. 2024 Feb 9;15(2):123

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6J mice YUMM1.7 melanoma model Intraperitoneal injection 20 mg/kg 4 consecutive days Delayed tumor growth and significantly improved mouse survival Mol Cancer Res. 2022 Dec 2;20(12):1811-1821

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.59mL

0.52mL

0.26mL

12.94mL

2.59mL

1.29mL

25.88mL

5.18mL

2.59mL

 

Historical Records

Categories